Table 1.
Participant Characteristics | n | (%) |
---|---|---|
Gender | ||
Men | 216 | 54.5% |
Women | 180 | 45.5% |
Ethnicity | ||
White | 197 | 49.7% |
African American | 175 | 44.2% |
Other | 24 | 6.0% |
Age | ||
18-20 | 164 | 41.0% |
21–23 | 236 | 59.0% |
Opioid abuse (lifetime) | 65 | 26.4% |
Dependence criteria (lifetime) | ||
0 | 120 | 30.3% |
1 | 125 | 31.6% |
2 | 102 | 25.8% |
3 or more | 49 | 22.4% |
Most common method of pharm. opioid administration (past 6 months) | ||
Oral | 328 | 83.0% |
Intranasal inhalation | 66 | 16.7% |
Other (excluding injection) | 1 | 0.3% |
Duration of illicit pharmaceutical opioid use in years, (Mean, Std.) |
4.1 (2.07) | |
Frequency of illicit pharmaceutical opioid use in the past 6 months |
||
Less than 1 day per month | 9 | 2.3% |
1-3 days per month | 99 | 25.0% |
1 day per week | 67 | 16.9% |
2 days per week | 126 | 31.8% |
3-5 days per week | 95 | 24.0% |
6-7 days per week | 0 | 0 |
Average number of days used illicit pharmaceutical opioids in the past month (Mean, Std) |
8.2 (6.3) | |
Average number of pharmaceutical opioid tablets used per day (Mean, Std) |
2.2 (0.4) |